Effect of Daily Ingestion of tea containing citrus ingredients on abdominal visceral fat area reduction: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000040109
• Lead Sponsor: Hokkaido Information University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-08
• Study Completion: 2020-10-17
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who are under physician's advice, treatment, and/or medication for dyslipidemia and/or diabetes. 2. Pacemaker or defibrillator users. 3. Subject who disagree to cooperate with grip strength test and leg strength test at the time of screening test. 4. Subjects with familial hypercholesterolemia. 5. Subjects whose fasting blood glucose values are more than 126 mg/dl. 6. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities. 7. Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 8. Subjects with unusually high and/or low blood pressure and/or abnormal physical data and hematological data. 9. Subjects with severe anemia. 10. Pre- or post-menopausal women complaining of obvious physical changes. 11. Subjects s who regularly drink green tea. 12. Subjects who has high caffeine sensitivity.Subjects who are at risk of having allergic reactions to drugs or foods. 13. Subjects who has high caffeine sensitivity. 14. Subjects who regularly take medicine, functional foods, and/or supplements which would affect lipid metabolism. 15. Subjects who regularly take medicine, functional foods, and/or supplements which would affect glucose metabolism. 16. Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 17. Subjects who donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks, or blood components within 2 weeks, prior to the current study. 18. Pregnant or lactating women or women who expect to be pregnant during this study. 19. Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study. 20. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified